- 2023/11/14[New Product] Completion of Development and Launch of Wnt3a Alternative Peptide (β-catenin pathway agonist)
- 2023/10/15Attended and presented at ISCCM2023
- 2023/10/11Participated in Cell and Gene Meeting on the Mesa
- 2023/10/11We had the exhibition booth at Regenerative Medicine Japan 2023
- 2023/09/05[New Product] Completion of Development and Launch of VEGF Alternative Peptide (VEGFR2 Agonist)
- 2023/08/22Joint Development of Novel Synthetic Peptide Based Growth Factor with Orizuru Therapeutics Inc.
- 2023/06/29The start of selling PG peptides at Tebubio
- 2023/05/23The start of selling PG peptides at Scientist.com and Stratech. 2023/05/23
- 2023/04/27Webinar：We made a presentation at the webinar organized by Good Food Institute(GFI).
- 2023/04/07Webinar: We held a webinar on Scientist.com.
- 2023/02/01A New article contribution to YODOSHA, “Experimental Medicine”, Special Issue. Title:’ Development of synthetic peptide growth factor and their future perspective’
- 2022/12/08New Products Release – BMP7 selective inhibitor and BMP4 selective inhibitor
- 2022/10/11New article in Nature – “A growing market for synthetically produced peptides”
- 2022/10/05PeptiGrowth exhibit Regenerative Medicine JAPAN and hold a mini-seminar (December 12-14, 2022)
- 2022/06/30New Product Release – BMP4,7 inhibitor (Noggin-like peptide)
- 2022/06/11Event – We will exhibit at ISSCR 2022 Annual Meeting at San Francisco, USA (June 15th-18th, 2022)
- 2022/05/11Event – We will exhibit at Advanced Therapies 2022 at ExCeL, London (May 24th-25th, 2022)
- 2022/03/31New Product Release – TrkB agonist peptide (BDNF alternative)
- 2021/12/02PeptiGrowth exhibit 3rd Regenerative Medicine Expo Tokyo and hold a mini-seminar (December 8th-10th, 2021)
- 2021/11/08New Product Release – TGFβ1 inhibitor (TGFβ1 binding peptide)
